| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 01/23/1996 | US5486526 Histamine H3 -receptor antagonists and therapeutic uses thereof |
| 01/18/1996 | WO1996001322A1 Serum paraoxonase |
| 01/18/1996 | CA2194390A1 Serum paraoxonase |
| 01/16/1996 | US5484944 Anxiety, sleep, memory |
| 01/10/1996 | EP0690863A1 Tetracyclic compounds as dopamine agonists |
| 01/09/1996 | US5482712 Galenic composition |
| 01/04/1996 | WO1996000073A1 Treatment of optic neuritis |
| 01/03/1996 | EP0689592A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/03/1996 | EP0513104B1 USE OF AN alpha-tocoPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED |
| 01/03/1996 | EP0462292B1 Salt eliminant composition |
| 01/03/1996 | CN1114207A Immunopotentiator for curing disease caused by toxic reaction of excessive free radicals |
| 01/02/1996 | US5480894 3-hydroxypyridin-4-one derivatives as chelating agents |
| 01/02/1996 | CA2032904C Blocking agents of edrf effect or formation for the treatment of shock |
| 12/28/1995 | WO1995035310A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 12/27/1995 | EP0379549B1 Endotoxin binding protein and uses thereof |
| 12/20/1995 | EP0687911A2 Methods for assaying endotoxin concentration |
| 12/20/1995 | EP0180581B2 Drug preparations of reduced toxicity |
| 12/14/1995 | WO1995033750A1 Corticotropin releasing factor antagonists |
| 12/14/1995 | WO1995033486A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof |
| 12/13/1995 | EP0686149A1 Use of 2-mercapto-imidazole derivatives substituted in position 4 (or 5) as antioxidizing agents, method of preparation and applications in the pharmaceutical, cosmetic or food industries |
| 12/12/1995 | US5475032 Treating strokes |
| 12/05/1995 | US5473077 4-aminopyrrolidine-2,4-substitude independently with carboxylic acid or 5-tetrazolyl for treating nervous system disorders and psychological disorders |
| 11/30/1995 | WO1995032205A1 Tricyclic dicarbonyl derivatives |
| 11/30/1995 | CA2189776A1 Tricyclic dicarbonyl derivatives |
| 11/29/1995 | EP0683669A1 Methods and compositions of a polymer (poloxamer) for cell repair |
| 11/28/1995 | US5470871 Therapeutic compositions based on 1,2-dithiole-3-thione derivatives |
| 11/28/1995 | US5470568 Nonionic polymer of ethylene oxide and propylene oxide for reduction of radiation damage |
| 11/28/1995 | CA2091986C Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands |
| 11/22/1995 | EP0682664A1 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 11/15/1995 | EP0682026A1 "Stable crystalline (6S)- and (6R)-tetrahydrofolic acid" |
| 11/15/1995 | CN1111506A Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals |
| 11/08/1995 | CN1111096A Antidotal health tea and processing method thereof |
| 11/02/1995 | EP0679160A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 10/31/1995 | US5463028 Compound comprising a methyl ecgonine group chemically attached to a phenylphosphonic group which is an analog to an intermediate of the hydrolysis transition-state of a cocaine benzoyl ester group |
| 10/25/1995 | EP0678031A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 10/25/1995 | EP0678022A1 Application of riluzole as a radiorestorer. |
| 10/24/1995 | CA1337415C Indole derivatives |
| 10/19/1995 | WO1995027485A1 Methods of using iron chelating compounds to reduce free radical damage in mammals |
| 10/17/1995 | CA1337352C Substituted propane-phosphinic acid compounds |
| 10/12/1995 | WO1995026716A1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments |
| 10/11/1995 | EP0676187A2 Composition containing a non photocatalytic metal oxide and tocopherol, its cosmetic and/or dermatologic use and methods for its preparation |
| 10/11/1995 | EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
| 10/11/1995 | CN1029972C Selective adenosine receptor compounds |
| 10/05/1995 | WO1995026352A1 IMIDAZO[1,2-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 10/05/1995 | WO1995026351A1 1,2,4-TRIAZOLO[4,3-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 10/05/1995 | WO1995026350A1 Imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one derivatives and pharmaceutical compositions containing same |
| 10/05/1995 | WO1995026349A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 10/05/1995 | WO1995026342A1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 10/05/1995 | DE4411225A1 Verwendung von Carbonsäurederivaten als Arzneimittel The use of carboxylic acid derivatives as medicaments |
| 10/05/1995 | CA2184754A1 5h-indeno[1,2-b]pyrazine-2,3-dione derivatives, preparation thereof and drugs containing same |
| 10/04/1995 | EP0674631A1 Substituted pyrazoles as crf antagonists |
| 10/04/1995 | EP0674628A1 New chemopreventive compounds and a preparation method and use thereof |
| 09/28/1995 | WO1995025721A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor |
| 09/28/1995 | DE4410822A1 Neue Piperidin-Derivate New piperidine derivatives |
| 09/28/1995 | CA2186010A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor |
| 09/26/1995 | CA1337124C Flavolignan derivatives, processes for the preparation thereof and pharmaceutical compositions containing these compounds |
| 09/20/1995 | EP0672127A1 Use of thiol redox proteins for reducing disulfide bonds |
| 09/13/1995 | CN1108098A Methods of inhibiting alzheimer's disease |
| 09/12/1995 | CA2039197C Pharmaceutic formulation for the treatment of alcoholism |
| 09/06/1995 | EP0617958A4 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions. |
| 09/05/1995 | US5447728 A carrier comprising an acylated amino acid; lowering iron concentration in mammals |
| 09/05/1995 | CA1336892C Anti-irritant and desensitizing compositions and methods of their use |
| 08/31/1995 | WO1995023156A1 Structure of a novel lipid a and methods utilizing same |
| 08/31/1995 | CA2184283A1 Structure of a novel lipid a and methods utilizing same |
| 08/30/1995 | CN1107359A Galenic composition |
| 08/29/1995 | CA1336825C Use and agent for reducing the side effects of tnf |
| 08/29/1995 | CA1336824C Method of safely providing anesthesia or conscious sedation |
| 08/29/1995 | CA1336823C Method of treating neurological disorders |
| 08/17/1995 | WO1995021844A1 5ht2b receptor antagonists condensed indoles |
| 08/17/1995 | WO1995021839A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 08/15/1995 | US5441737 Use of apotransferrin that has bound zinc or copper ions for treatment of toxic effects of endotoxins |
| 08/10/1995 | WO1995017876A3 2,4-disulphophenyl butylnitrone, its salts, and their use as pharmaceutical spintraps |
| 08/08/1995 | CA2002958C Boehmite-type aluminum hydroxide, process for preparing same and phosphate ion adsorbent containing same as effective component |
| 08/03/1995 | WO1995020587A1 Neuroprotective chroman compounds |
| 08/01/1995 | CA1336506C Method for protection from chemotherapeutic side effects |
| 07/27/1995 | WO1995009848A3 Polyazacycloalkanes as dichelants |
| 07/26/1995 | EP0416037B1 Superoxide dismutase analogs having novel binding properties |
| 07/25/1995 | CA1336398C Method for reducing side effects of cancer therapy |
| 07/18/1995 | US5434156 Use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders |
| 07/12/1995 | EP0526537B1 5-benzyl barbiturate derivatives |
| 07/11/1995 | CA1336287C Selective serotonin uptake inhibitors |
| 07/06/1995 | WO1995018108A1 Use of 2-mercapto-imidazole derivatives substituted in position 4 (or 5) as antioxidizing agents, method of preparation and applications in the pharmaceutical, cosmetic or food industries |
| 07/06/1995 | WO1995017876A2 2,4-disulphophenyl butylnitrone, its salts, and their use as pharmaceutical spintraps |
| 07/06/1995 | CA2156490A1 Use of 2-mercapto-imidazole derivatives substituted in position 4 (or 5) as antioxidizing agents, method of preparation and applications in the pharmaceutical, cosmetic or food industries |
| 07/05/1995 | EP0660719A1 Method and composition for ameliorating tissue damage due to ischemia and reperfusion |
| 07/04/1995 | CA1336192C Pharmaceutical benzoheterocyclylcarboxamide derivatives |
| 06/29/1995 | WO1995017410A1 Heterocyclic compounds |
| 06/29/1995 | CA2177851A1 Heterocyclic compounds |
| 06/28/1995 | EP0659418A1 2-Phenyl-3-azoylbenzothiophene for treating Alzheimer's disease |
| 06/28/1995 | EP0659402A2 Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals |
| 06/22/1995 | CA2138495A1 Methods of inhibiting alzheimer's disease |
| 06/21/1995 | EP0658160A1 Antipsychotic quinoline derivatives of benzodioxanmethylamine |
| 06/21/1995 | EP0658116A1 Methods useful in endotoxin prophylaxis and therapy |
| 06/15/1995 | WO1995015958A1 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 06/15/1995 | WO1995015758A1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase |
| 06/15/1995 | WO1995015756A1 Pharmaceutical formulation for preventing or pre-treating poisoning by organophosphoric cholinesterase inhibitors |
| 06/15/1995 | WO1995015755A1 Transdermal therapeutical system for preventing poisoning by organophosphoric nurotoxins that consists of a combination of active substances including a parasympathomimetic and a parasympatholytic agent |
| 06/14/1995 | EP0657520A1 Antioxidant |
| 06/14/1995 | EP0657169A1 Fruit polyphenol; process for production thereof; and antioxidant, hypotensive agent, antimutagenic agent, antiallergic agent and anticariogenic agent, each comprising said polyphenol |
| 06/13/1995 | US5424471 Crystalline amifostine compositions and methods of the preparation and use of same |